UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Update on Recent Developments in Small Molecular HIV-1 RNase H Inhibitors (2013-2016): Opportunities and Challenges

Current medicinal chemistry, 2018-01, Vol.25 (14), p.1682-1702

2018

Volltextzugriff (PDF)

17-nor-Cephalotane-Type Diterpenoids from Cephalotaxus fortunei

Journal of natural products (Washington, D.C.), 2019-06, Vol.82 (6), p.1565-1575

2019

Volltextzugriff (PDF)

Design, synthesis and biological evaluation of “Multi-Site”-binding influenza virus neuraminidase inhibitors

European journal of medicinal chemistry, 2019-09, Vol.178, p.64-80

2019

Volltextzugriff (PDF)

Novel 1,2,3-thiadiazole derivatives as HIV-1 NNRTIs with improved potency: Synthesis and preliminary SAR studies

Bioorganic & medicinal chemistry, 2009-08, Vol.17 (16), p.5920-5927

2009

Volltextzugriff (PDF)

1,2,3-Thiadiazole thioacetanilides as a novel class of potent HIV-1 non-nucleoside reverse transcriptase inhibitors

Bioorganic & medicinal chemistry letters, 2008-10, Vol.18 (20), p.5368-5371

2008

Volltextzugriff (PDF)

The Changing Face of Hepatitis C: Recent Advances on HCV Inhibitors Targeting NS5A

Current medicinal chemistry, 2015-05, Vol.22 (15), p.1860-1879

2015

Volltextzugriff (PDF)

A rational design strategy of the novel topoisomerase II inhibitors for the synthesis of the 4-O-(2-pyrazinecarboxylic)-4′-demethylepipodophyllotoxin with antitumor activity by diminishing the relaxation reaction of topoisomerase II-DNA decatenation

Bioorganic & medicinal chemistry, 2014-06, Vol.22 (11), p.2998-3007

2014

Volltextzugriff (PDF)

Arylazolyl(azinyl)thioacetanilides. Part 10: Design, synthesis and biological evaluation of novel substituted imidazopyridinylthioacetanilides as potent HIV-1 inhibitors

Bioorganic & medicinal chemistry, 2012-09, Vol.20 (18), p.5527-5536

2012

Volltextzugriff (PDF)

Arylazolyl(azinyl)thioacetanilide. Part 9: Synthesis and biological investigation of thiazolylthioacetamides derivatives as a novel class of potential antiviral agents

Archives of Pharmacal Research, 2012, 35(6), , pp.975-986

2012

Volltextzugriff (PDF)

Design, synthesis and biological evaluation of substituted guanidine indole derivatives as potential inhibitors of HIV-1 Tat-TAR interaction

Medicinal chemistry (Shp-sariqah, United Arab Emirates), 2014-01, Vol.10 (7), p.738-746

2014

Volltextzugriff (PDF)

Ligustrazine derivatives. Part 6: design, synthesis and evaluation of novel ligustrazinyl acylguanidine derivatives as potential cardiovascular agents

Medicinal chemistry (Shp-sariqah, United Arab Emirates), 2012-09, Vol.8 (5), p.928-933

2012

Volltextzugriff (PDF)

Ligustrazine derivatives. Part 8: design, synthesis, and preliminary biological evaluation of novel Ligustrazinyl amides as cardiovascular agents

Medicinal chemistry (Shp-sariqah, United Arab Emirates), 2014, Vol.10 (1), p.81-89

2014

Volltextzugriff (PDF)

Synthesis and anti-HIV activity evaluation of novel N′-arylidene-2-[1-(naphthalen-1-yl)-1H-tetrazol-5-ylthio]acetohydrazides

Medicinal chemistry research, 2010, Vol.19 (7), p.652-663

2010

Volltextzugriff (PDF)

Contemporary Medicinal Chemistry Strategies for the Discovery and Development of Novel HIV‑1 Non-nucleoside Reverse Transcriptase Inhibitors

Journal of medicinal chemistry, 2022-03, Vol.65 (5), p.3729-3757

2022

Volltextzugriff (PDF)

Escaping from Flatland: Multiparameter Optimization Leads to the Discovery of Novel Tetrahydropyrido[4,3‑d]pyrimidine Derivatives as Human Immunodeficiency Virus‑1 Non-nucleoside Reverse Transcriptase Inhibitors with Superior Antiviral Activities against Non-nucleoside Reverse Transcriptase Inhibitor-Resistant Variants and Favorable Drug-like Profiles

Journal of medicinal chemistry, 2023-07, Vol.66 (13), p.8643-8665

2023

Volltextzugriff (PDF)

Discovery of Novel Dihydrothiopyrano[4,3‑d]pyrimidine Derivatives as Potent HIV‑1 NNRTIs with Significantly Reduced hERG Inhibitory Activity and Improved Resistance Profiles

Journal of medicinal chemistry, 2021-09, Vol.64 (18), p.13658-13675

2021

Volltextzugriff (PDF)

Discovery of Novel Aryl Triazolone Dihydropyridines (ATDPs) Targeting Highly Conserved Residue W229 as Promising HIV‑1 NNRTIs

Journal of medicinal chemistry, 2024-04, Vol.67 (8), p.6570-6584

2024

Volltextzugriff (PDF)

Discovery of 2,4,6-trisubstituted pyrimidine derivatives as novel potent HIV-1 NNRTIs by exploiting the tolerant region II of the NNIBP

European journal of medicinal chemistry, 2024-11, Vol.277, p.116708, Article 116708

2024

Volltextzugriff (PDF)

Discovery of a Novel Thienopyrimidine Compound as a Urate Transporter 1 and Glucose Transporter 9 Dual Inhibitor with Improved Efficacy and Favorable Druggability

Journal of medicinal chemistry, 2024-03, Vol.67 (6), p.5032-5052

2024

Volltextzugriff (PDF)

2,4,5-Trisubstituted Pyrimidines as Potent HIV‑1 NNRTIs: Rational Design, Synthesis, Activity Evaluation, and Crystallographic Studies

Journal of medicinal chemistry, 2021-04, Vol.64 (7), p.4239-4256

2021

Volltextzugriff (PDF)

Structure-Based Design of Novel G‑Protein-Coupled Receptor TAAR1 Agonists as Potential Antipsychotic Drug Candidates

Journal of medicinal chemistry, 2024-03, Vol.67 (5), p.4234-4249

2024

Volltextzugriff (PDF)

Design, synthesis and anti-HBV activity study of novel HBV capsid assembly modulators

Bioorganic & medicinal chemistry letters, 2024-11, Vol.112, p.129913, Article 129913

2024

Volltextzugriff (PDF)

Development of Novel Dihydrofuro[3,4‑d]pyrimidine Derivatives as HIV‑1 NNRTIs to Overcome the Highly Resistant Mutant Strains F227L/V106A and K103N/Y181C

Journal of medicinal chemistry, 2022-02, Vol.65 (3), p.2458-2470

2022

Volltextzugriff (PDF)

Identification of Dihydrofuro[3,4‑d]pyrimidine Derivatives as Novel HIV‑1 Non-Nucleoside Reverse Transcriptase Inhibitors with Promising Antiviral Activities and Desirable Physicochemical Properties

Journal of medicinal chemistry, 2019-02, Vol.62 (3), p.1484-1501

2019

Volltextzugriff (PDF)

Design, Synthesis, and Biological Evaluation of Novel Thioureidobenzamide (TBA) Derivatives as HBV Capsid Assembly Modulators

Journal of medicinal chemistry, 2023-10, Vol.66 (20), p.13968-13990

2023

Volltextzugriff (PDF)

1 – 25 von 51

Suche als RSS-Feed

Aktive Filter

ThemaChemistry, Medicinal

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(50)
Mit Volltextzugriff
(46)

Publikationsform

Artikel
(51)

Sprache

Englisch
(51)

Erscheinungsjahr

n.n

Neu hinzugefügt

... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Update on Recent Developments in Small Molecular HIV-1 RNase H Inhibitors (2013-2016): Opportunities and Challenges

17-nor-Cephalotane-Type Diterpenoids from Cephalotaxus fortunei

Design, synthesis and biological evaluation of “Multi-Site”-binding influenza virus neuraminidase inhibitors

Novel 1,2,3-thiadiazole derivatives as HIV-1 NNRTIs with improved potency: Synthesis and preliminary SAR studies

1,2,3-Thiadiazole thioacetanilides as a novel class of potent HIV-1 non-nucleoside reverse transcriptase inhibitors

The Changing Face of Hepatitis C: Recent Advances on HCV Inhibitors Targeting NS5A

A rational design strategy of the novel topoisomerase II inhibitors for the synthesis of the 4-O-(2-pyrazinecarboxylic)-4′-demethylepipodophyllotoxin with antitumor activity by diminishing the relaxation reaction of topoisomerase II-DNA decatenation

Arylazolyl(azinyl)thioacetanilides. Part 10: Design, synthesis and biological evaluation of novel substituted imidazopyridinylthioacetanilides as potent HIV-1 inhibitors

Arylazolyl(azinyl)thioacetanilide. Part 9: Synthesis and biological investigation of thiazolylthioacetamides derivatives as a novel class of potential antiviral agents

Design, synthesis and biological evaluation of substituted guanidine indole derivatives as potential inhibitors of HIV-1 Tat-TAR interaction

Ligustrazine derivatives. Part 6: design, synthesis and evaluation of novel ligustrazinyl acylguanidine derivatives as potential cardiovascular agents

Ligustrazine derivatives. Part 8: design, synthesis, and preliminary biological evaluation of novel Ligustrazinyl amides as cardiovascular agents

Synthesis and anti-HIV activity evaluation of novel N′-arylidene-2-[1-(naphthalen-1-yl)-1H-tetrazol-5-ylthio]acetohydrazides

Contemporary Medicinal Chemistry Strategies for the Discovery and Development of Novel HIV‑1 Non-nucleoside Reverse Transcriptase Inhibitors

Discovery of Novel Dihydrothiopyrano[4,3‑d]pyrimidine Derivatives as Potent HIV‑1 NNRTIs with Significantly Reduced hERG Inhibitory Activity and Improved Resistance Profiles

Discovery of Novel Aryl Triazolone Dihydropyridines (ATDPs) Targeting Highly Conserved Residue W229 as Promising HIV‑1 NNRTIs

Discovery of 2,4,6-trisubstituted pyrimidine derivatives as novel potent HIV-1 NNRTIs by exploiting the tolerant region II of the NNIBP

Discovery of a Novel Thienopyrimidine Compound as a Urate Transporter 1 and Glucose Transporter 9 Dual Inhibitor with Improved Efficacy and Favorable Druggability

2,4,5-Trisubstituted Pyrimidines as Potent HIV‑1 NNRTIs: Rational Design, Synthesis, Activity Evaluation, and Crystallographic Studies

Structure-Based Design of Novel G‑Protein-Coupled Receptor TAAR1 Agonists as Potential Antipsychotic Drug Candidates

Design, synthesis and anti-HBV activity study of novel HBV capsid assembly modulators

Development of Novel Dihydrofuro[3,4‑d]pyrimidine Derivatives as HIV‑1 NNRTIs to Overcome the Highly Resistant Mutant Strains F227L/V106A and K103N/Y181C

Identification of Dihydrofuro[3,4‑d]pyrimidine Derivatives as Novel HIV‑1 Non-Nucleoside Reverse Transcriptase Inhibitors with Promising Antiviral Activities and Desirable Physicochemical Properties

Design, Synthesis, and Biological Evaluation of Novel Thioureidobenzamide (TBA) Derivatives as HBV Capsid Assembly Modulators

Aktive Filter

Suchergebnisse filtern